论文部分内容阅读
目的:对盐酸左氧氟沙星在妇科盆腔炎疾病治疗中的临床效果以及安全性进行探讨。方法:择选2013年11月到2014年11月我院妇科所接收的88例盆腔炎患者作为研究的对象,按就诊先后顺序分成两组,即甲组与乙组,其中甲组患者予以氧氟沙星加以治疗,乙组患者予以左氧氟沙星加以治疗,且对其治疗的效果及其不良反应等进行观察与比较。结果:甲组中患者的有效率为93.2%(41/44),乙组中患者的有效率为81.8%(36/44),两组相比有差异,具备统计学意义(P<0.05);甲组中患者的不良反应发生率为4.5%(2/44),乙组中患者的不良反应发生率为18.2%(8/44),两组相比有差异,具备统计学意义(P<0.05)。结论:对患有盆腔炎疾病的患者采取盐酸左氧氟沙星进行治疗,疗效确切,且不良反应发生率低,值得大力推广。
Objective: To investigate the clinical effect and safety of levofloxacin hydrochloride in the treatment of gynecological pelvic inflammatory disease. Methods: From November 2013 to November 2014, 88 cases of pelvic inflammatory disease received by the gynecological hospital of our hospital were selected as the research objects, divided into two groups according to the order of treatment: group A and group B, in which group A patients were given oxygen Ofloxacin to be treated, patients with levofloxacin B group to be treated, and its treatment and adverse reactions were observed and compared. Results: The effective rate was 93.2% (41/44) in group A and 81.8% (36/44) in group B. The differences between the two groups were statistically significant (P0.05) . The adverse reaction rate of patients in group A was 4.5% (2/44), and the rate of adverse reactions in group B was 18.2% (8/44). There was significant difference between the two groups (P <0.05). Conclusions: Levofloxacin hydrochloride for patients with pelvic inflammatory disease is effective and effective, with a low incidence of adverse reactions and is worth promoting.